Connection

Anvar Kaleeckal to Humans

Back to Details
This is a "connection" page, showing publications Anvar Kaleeckal has written about Humans.
Anvar Kaleeckal
Connection Strength
0.015
Humans
  1. Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses. J Travel Med. 2021 10 11; 28(7).
    View in: PubMed
    Score: 0.002
  2. Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting. Clin Infect Dis. 2021 10 05; 73(7):e1830-e1840.
    View in: PubMed
    Score: 0.002
  3. mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar. Nat Med. 2021 09; 27(9):1614-1621.
    View in: PubMed
    Score: 0.002
  4. Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population. Sci Rep. 2021 06 04; 11(1):11837.
    View in: PubMed
    Score: 0.002
  5. Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar. Emerg Infect Dis. 2021 05; 27(5):1343-1352.
    View in: PubMed
    Score: 0.002
  6. Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic. Sci Rep. 2021 03 18; 11(1):6233.
    View in: PubMed
    Score: 0.002
  7. Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19. J Glob Health. 2021 Jan 16; 11:05005.
    View in: PubMed
    Score: 0.002
  8. Two prolonged viremic SARS-CoV-2 infections with conserved viral genome for two months. Infect Genet Evol. 2021 03; 88:104684.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.